Bioceltix Ratios and Metrics

Market cap in millions PLN. Fiscal year is January - December.

Millions PLN. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021
Period Ending	Sep '24 Sep 27, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	342	372	133	172
Market Cap Growth	15.76%	179.48%	-22.49%	-
Enterprise Value	322	357	130	-
Last Close Price	69.50	90.00	38.80	52.20
PE Ratio	-	-25.77	-14.51	-37.52
PB Ratio	7.62	35.51	25.82	28.60
P/FCF Ratio	-22.69	-24.44	-16.16	-42.63
P/OCF Ratio	-22.86	-25.20	-16.89	-42.70
EV/EBITDA Ratio	-19.76	-26.32	-15.24	-
EV/EBIT Ratio	-19.21	-25.50	-14.48	-
EV/FCF Ratio	-23.29	-23.50	-15.76	-
Debt / Equity Ratio	0.00	0.02	0.06	0.09
Debt / FCF Ratio	-0.02	-0.01	-0.04	-0.13
Quick Ratio	3.26	5.23	1.94	3.41
Current Ratio	7.21	5.24	2.68	3.42
Return on Equity (ROE)	-50.19%	-175.28%	-160.02%	-
Return on Assets (ROA)	-28.03%	-85.92%	-70.62%	-
Return on Capital (ROIC)	-31.71%	-108.90%	-93.47%	-
Earnings Yield	-5.47%	-3.68%	-6.71%	-2.56%
FCF Yield	-4.05%	-4.09%	-6.19%	-2.35%
Buyback Yield / Dilution	-16.64%	-17.48%	-5.54%	-
Total Shareholder Return	-16.64%	-17.48%	-5.54%	-

Source: S&P Capital IQ. Standard template. Financial Sources.